在儿科患者中治疗囊性纤维化 - - 从临床特征到个性化治疗
Alice Nicoleta Azoicai1, Ancuta Lupu1, Laura Mihaela Trandafir1
1Pediatrics, "Grigore T. Popa" University of Medicine and Pharmacy, Iasi, Romania.
Frontiers in pediatrics
|May 27, 2024
概括
囊性纤维化 (CF) 是一种影响囊性纤维化跨膜导电性调节器 (CFTR) 基因的遗传性疾病. 对不常见的CF突变的研究对于个性化医学和改善患者治疗结果至关重要.
科学领域:
- 遗传学和分子生物学
- 儿科医学 儿科医学
- 医学诊断 医学诊断 医学诊断
背景情况:
- 囊性纤维化 (CF) 是一种由CFTR基因突变引起的单一性,自体衰退性疾病,历来影响北欧人口.
- 这是一种普遍的缩短生命的疾病,诊断传统上依赖于汗液化物测试 (SCT).
- 最近的进展使得通过基因突变识别的诊断成为可能,即使是边界SCT结果.
研究的目的:
- 评估和改善儿童CF患者的治疗方案,以进行早期干预.
- 突出研究不常见的CF突变的重要性,以改善患者护理和预后.
- 强调基因研究在开发新的,个性化的CF治疗中的作用.
主要方法:
- 对囊性纤维化病的诊断方法的审查.
- 对针对CFTR通路的当前和新兴治疗策略的分析.
- 探索CF中的基因型-表型相关性,特别是罕见突变.
主要成果:
- 现在CF的双重诊断标准包括与SCT一起发现基因突变.
- 向分子疗法为儿科CF患者提供高效,个性化的护理.
- 了解罕见突变是预测疾病进展和定制治疗的关键.
结论:
- 在儿科CF治疗中,早期和积极的干预至关重要.
- 由遗传研究驱动的个性化医学对于改善生活质量至关重要,特别是对于不常见的CF突变患者.
- 为了开发先进的治疗方法,需要进一步了解CF的发病性.
相关概念视频
Cystic Fibrosis: Management
155
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
155
Cystic Fibrosis: Pathogenesis
218
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
218
COPD: Pathogenesis and Clinical Features
259
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
259
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Chronic Obstructive Pulmonary Disease-V: Nursing Management
3.8K
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Assessment
3.8K
Chronic Pancreatitis II: Collaborative Care
84
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
84


